Ladenburg Thalmann Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$568K	Buy	15,728 +6,152	+64%	+$189K	﹤0.01%	1708
2019 Q3	$261K	Buy	9,576 +1,912	+25%	+$49.4K	﹤0.01%	2265
2019 Q2	$185K	Sell	7,664 -2,212	-22%	-$56.1K	﹤0.01%	2534
2019 Q1	$261K	Sell	9,876 -664	-6%	-$15.7K	﹤0.01%	2196
2018 Q4	$208K	Buy	10,540 +1,327	+14%	+$26K	﹤0.01%	2221
2018 Q3	$180K	Buy	9,213 +122	+1%	+$2.32K	﹤0.01%	2397
2018 Q2	$128K	Hold	9,091	–	–	﹤0.01%	2594
2018 Q1	$128K	Buy	9,091 +3,877	+74%	+$57.3K	﹤0.01%	2594
2017 Q4	$76K	Sell	5,214 -908	-15%	-$12.8K	﹤0.01%	2930
2017 Q3	$78K	Buy	6,122 +788	+15%	+$10K	﹤0.01%	2769
2017 Q2	$63K	Sell	5,334 -1,211	-19%	-$15.1K	﹤0.01%	2872
2017 Q1	$96K	Sell	6,545 -1,998	-23%	-$32.4K	﹤0.01%	2437
2016 Q4	$139K	Sell	8,543 -10,038	-54%	-$182K	﹤0.01%	2076
2016 Q3	$336K	Sell	18,581 -5,835	-24%	-$114K	0.01%	1416
2016 Q2	$402K	Sell	24,416 -1,704	-7%	-$27.6K	0.01%	1263
2016 Q1	$433K	Sell	26,120 -1,768	-6%	-$30.9K	0.01%	1138
2015 Q4	$603K	Buy	27,888 +16,099	+137%	+$313K	0.01%	924
2015 Q3	$237K	Buy	11,789 +5,582	+90%	+$176K	﹤0.01%	1371
2015 Q2	$215K	Buy	6,207 +5,834	+1,564%	+$178K	﹤0.01%	1567
2015 Q1	$8K	Buy	+373	New	+$6.84K	﹤0.01%	3781
2014 Q4	–	Sell	-205	Closed	-$3K	–	4491
2014 Q3	$3K	Hold	205	–	–	﹤0.01%	3612
2014 Q2	$3K	Buy	+205	New	+$2.93K	﹤0.01%	3574

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ladenburg Thalmann Financial Services's HZNP Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 64% in Q4 2019, buying an estimated $189K and bringing the position to 15,728 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Ladenburg Thalmann Financial Services first reported a position in HZNP in Q2 2014 and has held it in 22 quarters since. The position peaked at $603K in Q4 2015. 281 funds tracked by Wall St. Rank hold HZNP as of Q4 2019.

Ladenburg Thalmann Financial Services held 15,728 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $568K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 6,152 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2019, an estimated $189K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1708 holding.
Ladenburg Thalmann Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and has held it in 22 quarters since.
Ladenburg Thalmann Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $603K in Q4 2015.
281 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.